Clinical Trial

A Study to Evaluate the Safety and Effectiveness of MSP01-T for Bowel Cleansing Before a Colonoscopy

Study acronym: MSP01
Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated September 25, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is being conducted to evaluate the safety and effectiveness of MSP01-T, a new bowel cleansing agent, in adults who are scheduled to undergo a colonoscopy. Participants will be randomly assigned to receive either MSP01-T or a comparator product. The study will assess how effectively MSP01-T cleans the bowel before the procedure and monitor any potential side effects. Adults aged 19 years and older who are planning to have a colonoscopy may be eligible to take part.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-11; most recent amendment 2025-09-24.
Trial Details
NCT Number NCT07181148
Lead Sponsor Mather's Pharm. Co., Ltd.
Conditions Colonoscopy, Bowel Preparation
Enrollment 214 participants
Start Date 2025-10
Primary Completion 2026-03 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-09-25